Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Distinction between anxiety state/trait in general practice: a descriptive study].

R Jouvent1, C Bungener, P Morand

  • 1CNRS UMR 7593, Hôpital de la Salpêtrière, Paris.

L'Encephale
|April 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[New lights on infectious mononucleosis].

Virologie (Montrouge, France)·2021
Same author

SARS-CoV-2 nosocomial infection acquired in a French university hospital during the 1st wave of the Covid-19 pandemic, a prospective study.

Antimicrobial resistance and infection control·2021
Same author

Epidemiology and clinical characteristics of Klebsiella spp. meningitis in France.

Infectious diseases now·2021
Same author

[Network model of mental disorders: Application and interest in post-stroke depression].

L'Encephale·2020
Same author

COVID-19 in clinical practice: A narrative synthesis.

Medecine et maladies infectieuses·2020
Same author

Six-week antibiotic therapy after one-stage replacement arthroplasty for hip and knee periprosthetic joint infection.

Medecine et maladies infectieuses·2020
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

This study found that trait-anxiety, a personality trait, predicts benzodiazepine (BZD) treatment effectiveness for anxiety. Higher trait-anxiety indicates a need for longer treatment duration.

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • State-anxiety is a temporary emotional response to stress.
  • Trait-anxiety is a personality trait influencing the likelihood of experiencing state anxiety.

Purpose of the Study:

  • To assess trait and state-anxiety in patients with anxiety complaints.
  • To compare outcomes for patients who stopped or continued benzodiazepine (BZD) treatment.

Main Methods:

  • 1,112 patients with anxiety complaints were evaluated.
  • Patients were assessed at baseline (D0), 3 months (M3), and 6 months (M6).
  • Evaluations included the Covi anxiety scale, Raskin depression scale, CGI, and Spielberger state/trait-anxiety questionnaire.

Main Results:

  • Anxiety scores significantly decreased by M6 (p = 0.0001).

Related Experiment Videos

  • Patients who stopped BZD treatment at M3 had lower trait-anxiety scores and less severe symptoms at baseline.
  • Trait-anxiety was a significant predictor of BZD treatment efficacy.
  • Conclusions:

    • Trait-anxiety levels influence the required duration of benzodiazepine treatment.
    • Patients with higher trait-anxiety may need longer treatment for anxiety management.
    • Lower trait-anxiety at baseline may predict successful discontinuation of BZD treatment.